| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.038 | 0.8 |